Exploratory Study of Natural Killer Inflammatory Lymphocytes in Waste Per-operating of Tonsillectomy

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03311919

Acronym

LINK

Enrollment

Registered

2017-10-17

Start date

2014-01-31

Completion date

2014-12-31

Last updated

2017-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tonsillectomy

Brief summary

The aim of this study is to describe the frequency of the presence of cells Natural Killer (NK) expressing CD86 and HLA - DR in tonsils

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* patient with programmed tonsillectomy as part of the care

Exclusion criteria

* patient opposition to use its waste of per-operating tonsillectomy for research purposes * patient with immunosuppressive and/or corticoid treatment (\> 1 mg/kg)

Design outcomes

Primary

Measure	Time frame	Description
presence of lymphocytes NK expressing CD86 and HLA - DR	inclusion	by immunostaining and detection by flow cytometry

Outcome results